Flibanserin: First Global Approval. - Test2 - elhamkhani - TriplyDB

Flibanserin: First Global Approval.

Flibanserin: First Global Approval.

http://www.wikidata.org/entity/Q38594117

about

Balance of the Sexes: Addressing Sex Differences in Preclinical Research Retinal Neuroprotective Effects of Flibanserin, an FDA-Approved Dual Serotonin Receptor Agonist-Antagonist Flibanserin for hypoactive sexual desire disorder: place in therapy Preclinical Abuse Potential Assessment of Flibanserin: Effects on Intracranial Self-Stimulation in Female and Male Rats.

P2860

Q26746163-19B47158-D70F-4895-A332-8157A775BED3 Q28552843-6FD0AA81-C5C6-4F69-8129-1A1C6CB2C16F Q34551331-89B34EC6-864F-4FE4-B591-1BA9891490B3 Q36655856-0E0F4299-9BAB-417E-8BDB-2FF0A66C5283

P2860

Flibanserin: First Global Approval.

http://www.wikidata.org/entity/Q38594117

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Flibanserin: First Global Approval.

@en

type

label

Flibanserin: First Global Approval.

@en

prefLabel

Flibanserin: First Global Approval.

@en

P1433

Q38594117-6DA4DCC7-FE42-4917-91EA-2EBD114A86D5

P1476

Q38594117-1308E8FC-4960-4CD9-A3D7-313766F6B7C7

P2093

Q38594117-86333343-B8DC-4F50-AEE4-937012C49364

P2860

Q38594117-03271792-B72A-447C-9A2A-2033A1BC0256

Q38594117-0790597C-4339-40C1-9C44-C3A1F7733F61

Q38594117-0F057069-A6E4-41B5-81BA-448E66FF0477

Q38594117-3454E3A3-D76B-4443-AC09-37C4E9A0F948

Q38594117-40397A5E-7BA3-4F88-A528-0095D4D42E93

Q38594117-4E994F2A-E12F-445C-9E84-2670144B5BE8

Q38594117-5B36F69D-3FE6-4EB3-83B6-CB979A35BB6A

Q38594117-64B5D260-E303-4723-BE01-19105F3B514A

Q38594117-70A8C271-6980-4033-B029-D5D78ACDB3E0

Q38594117-7A7C1BFC-A799-4E59-A057-6199EC916B6B

P2888

Q38594117-12EF9688-AD2F-4B5B-8004-0B7D4F01C2AC

P304

Q38594117-C6FF81A3-A3EB-41F7-A626-6D950387E31D

P31

Q38594117-4AEC0F90-6BD2-4531-BBB3-8A0CB5E43946

P356

Q38594117-85B85831-42ED-4CC5-A893-0672189C78B5

P433

Q38594117-3AB89276-238B-4086-AB8E-07A9D2C06205

P478

Q38594117-C5181A5E-9B13-440E-83C1-47E0949EE5D0

P577

Q38594117-DCE3BD20-93BE-454E-A316-02CE8D1DF6CC

P6179

Q38594117-4BA7E210-B145-443F-9489-2206EF79B71F

P698

Q38594117-12EF6C5E-493C-4115-81D0-2BC693939858

P921

Q38594117-CC80790B-2825-421F-B950-C2FD77F69DC7

P356

S40265-015-0474-Y

P1433

P1476

Flibanserin: First Global Approval.

@en

P2093

Emma D Deeks

http://www.w3.org/2001/XMLSchema#string

P2860

Flibanserin and 8-OH-DPAT implicate serotonin in association between female marmoset monkey sexual behavior and changes in pair-bond quality.

Flibanserin, a potential antidepressant drug, lowers 5-HT and raises dopamine and noradrenaline in the rat prefrontal cortex dialysate: role of 5-HT(1A) receptors

Region-dependent effects of flibanserin and buspirone on adenylyl cyclase activity in the human brain

Acute and repeated flibanserin administration in female rats modulates monoamines differentially across brain areas: a microdialysis study

Mechanism of action of flibanserin, a multifunctional serotonin agonist and antagonist (MSAA), in hypoactive sexual desire disorder.

Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the DAISY study.

Hypoactive sexual desire disorder in women: treatment options beyond testosterone and approaches to communicating with patients on sexual health.

Efficacy and safety of flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the SNOWDROP trial.

Capsule commentary on Joynt et al., The impact of neighborhood socioeconomic status and race on the prescribing of opioids in emergency departments throughout the United States.

Electrophysiological examination of the effects of sustained flibanserin administration on serotonin receptors in rat brain.

P2888

s40265-015-0474-y

P304

1815-1822

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40265-015-0474-Y

http://www.w3.org/2001/XMLSchema#string

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

75

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1023012550

http://www.w3.org/2001/XMLSchema#string

P698

26412054

http://www.w3.org/2001/XMLSchema#string

P921